North America Mutation Detection Kits In Genome Editing Market Size & Outlook
Related Markets
North America mutation detection kits in genome editing market highlights
- The North America mutation detection kits in genome editing market generated a revenue of USD 48,796.9 million in 2020.
- The market is expected to grow at a CAGR of 17.2% from 2021 to 2028.
- In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2020.
- Meganuclease is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2021 to 2028.
North America data book summary
| Market revenue in 2020 | USD 48,796.9 million |
| Market revenue in 2028 | USD 173,550.2 million |
| Growth rate | 17.2% (CAGR from 2020 to 2028) |
| Largest segment | (crispr)/cas9 |
| Fastest growing segment | Meganuclease |
| Historical data covered | 2017 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
| Key market players worldwide | Thermo Fisher Scientific Inc, Takara Bio Inc, Danaher Corp, Promega, GenScript ProBio, New England Biolabs, Applied Materials Inc, Bio-Rad Laboratories Inc, Lucigen, Synthego, Addgene, Abcam PLC |
Other key industry trends
- In terms of revenue, North America region accounted for 38.4% of the global mutation detection kits in genome editing market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 162,918.0 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Mutation Detection Kits In Genome Editing Market Scope
Mutation Detection Kits In Genome Editing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Lucigen | View profile | 11-50 | Middleton, Wisconsin, United States, North America | http://lucigen.com |
| Synthego | View profile | 251-500 | Redwood City, California, United States, North America | http://www.synthego.com |
| Addgene | View profile | 11-50 | Cambridge, Massachusetts, United States, North America | http://www.addgene.org/ |
| Applied Materials Inc | View profile | 34000 | 3050 Bowers Avenue, P.O. Box 58039, Santa Clara, CA, United States, 95052-8039 | https://www.appliedmaterials.com |
| Promega | View profile | 5001-10000 | Madison, Wisconsin, United States, North America | http://www.promega.com/es |
| GenScript ProBio | View profile | 1001-5000 | Nanjing, Jiangsu, China, Asia | https://www.genscriptprobio.cn |
| New England Biolabs | View profile | 501-1000 | Ipswich, Massachusetts, United States, North America | http://neb.com |
| Abcam PLC | View profile | 1760 | Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AX | https://www.abcam.com |
| Takara Bio Inc | View profile | 1793 | Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058 | http://www.takara-bio.co.jp |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
North America mutation detection kits in genome editing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mutation detection kits in genome editing market will help companies and investors design strategic landscapes.
(crispr)/cas9 was the largest segment with a revenue share of 42.99% in 2020. Horizon Databook has segmented the North America mutation detection kits in genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2017 to 2028.
High investments in R&D, continuous technological developments by key players, availability of technologically advanced healthcare infrastructure, and a strong regional economy have resulted in North America’s current dominance in the global market. In addition, local presence of key operating players in the region can further strengthen regional revenue generation.
GeneScript, Thermo Fisher Scientific, Takara Bio USA are some prominent players operating in North America. Furthermore, government initiatives in the U.S. and Canada are supporting research in therapeutic development in oncology space.
For instance, the Personalized Onco-Genomics program of the BC Cancer utilizes whole-genome and transcriptome analysis for the determination of cancer genes and identification of corresponding drugs that may inhibit relevant pathways in cancer-affected patients.
Reasons to subscribe to North America mutation detection kits in genome editing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America mutation detection kits in genome editing market databook
-
Our clientele includes a mix of mutation detection kits in genome editing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America mutation detection kits in genome editing market , including forecasts for subscribers. This continent databook contains high-level insights into North America mutation detection kits in genome editing market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
North America mutation detection kits in genome editing market size, by country, 2017-2028 (US$M)
North America Mutation Detection Kits In Genome Editing Market Outlook Share, 2020 & 2028 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
